ImageneBio (IMA) EBITDA Margin (2020 - 2026)
ImageneBio (IMA) recorded EBITDA Margin of -749.13% in Q1 2025.
Powered by 
Analysis
ImageneBio (IMA) EBITDA Margin (2020 - 2026) Analysis & Trends
For FY2023, ImageneBio reported EBITDA Margin of -812.19%, down 363.01 percentage points from FY2022.
- Annual EBITDA Margin has a three-year change of -331.24 percentage points (FY2020 to FY2023).
- Across earlier years, EBITDA Margin came in at -449.18% in FY2022 (-340.76 pp), -108.42% in FY2021 (+372.53 pp) and -480.95% in FY2020.
- The Q1 2025 figure is the lowest quarterly EBITDA Margin since Q4 2023.
- On a year-over-year basis, EBITDA Margin rose in two of the last four quarters, with an average year-over-year change of +437.71 percentage points.
- Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 39980.77 percentage points in Q4 2021, against a drop of 5091.15 percentage points in Q2 2022 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 36.69% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 40.60% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 39.77% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 42.49% |
| 10 | ImageneBio | 65.24 Mn | -450.07 Mn | - | -1,455.76% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -1,455.76% |
| Jun 30, 2026 | -944.23% |
| Mar 31, 2026 | -1,069.88% |
| Dec 31, 2025 | -658.39% |
| Mar 31, 2025 | -749.13% |
| Dec 31, 2024 | -93,656.67% |
| Sep 30, 2024 | -55.60% |
| Dec 31, 2023 | -3,278.15% |
| Sep 30, 2023 | -1,625.40% |
| Jun 30, 2023 | -910.58% |
| Mar 31, 2023 | -287.67% |
| Dec 31, 2022 | -273.47% |
| Sep 30, 2022 | -275.90% |
| Jun 30, 2022 | -5,445.81% |
| Mar 31, 2022 | -495.92% |
| Dec 31, 2021 | 14.62% |
| Sep 30, 2021 | -385.00% |
| Jun 30, 2021 | -354.66% |
| Mar 31, 2021 | -276.91% |
| Dec 31, 2020 | -39,966.15% |
API Access
ImageneBio EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=IMA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "IMA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=IMA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();